White paper on the promotion of an integrated risk assessment concept in European regulatory frameworks for chemicals
Introduction
Since the late 1970s, risk assessment (RA) of chemicals has served the needs of health and environment protection policies worldwide. While extensive cumulative experience has been gained over time in chemical RA, and new regulations have been established for a wide range of chemical stressors, current regulatory RA practice for chemicals faces substantial challenges to meet present and future scientific, ethical and policy needs.
Anticipating the changing needs of RA processes, an international expert group involving the European Commission (EC), the US Environmental Protection Agency (US EPA) and the Organisation for Economic Cooperation and Development (OECD) was set up in 1998 under the umbrella of the International Programme on Chemical Safety (IPCS) of the World Health Organization (WHO) to advance the integration of approaches for human health risk assessment (HHRA) and ecological (environmental) risk assessment (ERA) to better inform risk-based decision making. Their seminal report (WHO, 2001) outlined a generic framework for integrated risk assessment (IRA) which can be used as guidance applicable to all chemical categories and which addresses real life multi-chemical, multimedia, multi-route and multispecies exposures. IRA was defined as “a science-based approach that combines the processes of risk estimation for humans, biota and natural resources in one assessment” (WHO, 2001). Based on four case studies (Hansen et al., 2003, Ross and Birnbaum, 2003, Sekizawa et al., 2003, Vermeire et al., 2003), benefits, opportunities, limitations and obstacles to using the framework were identified, and research recommendations were made to improve and facilitate integrated approaches (Munns et al., 2003).
In 2003, the EC highlighted IRA as a key element of future action in its European Environment and Health Strategy (EC, 2003), paving the way for the development of the IRA concept as new EU research projects under the 6th Framework Programme (FP6) (e.g. HEIMTSA (http://cordis.europa.eu/project/rcn/81281_en.html), INTARESE (http://www.intarese.org/), NoMiracle (http://nomiracle.jrc.ec.europa.eu/), OSIRIS (http://www.ufz.de/osiris/), 2-FUN (http://www.2-fun.org/)) were funded to better characterize the link between environmental risk factors and health-related impacts. Building on this legacy, the FP7 coordination project HEROIC1 aimed to consolidate the existing knowledge and identify what is necessary to further develop and promote IRA.
Based on the HEROIC project's major findings, this white paper presents a vision of IRA focused on opportunities and challenges in relation to specific EU chemical regulatory frameworks, including policy recommendations on how to promote the implementation of IRA. Although our focus is on regulatory RA in the context of sectorial chemical regulations and marketing authorization of chemicals, we appreciate that the concept of IRA can also be applied to other areas and types of RA, e.g. community-based RA, which is associated with public health issues and deals with population-based or ecological requirements.
Section snippets
What is integrated risk assessment?
Integration can be applied in various contexts and at different levels of complexity in chemical RA (Bridges, 2003, Briggs, 2008, Kortenkamp and Faust, 2004, Suter et al., 2003). One can integrate components such as exposure and effects; in silico, in vitro, in vivo or monitoring data; multiple chemicals, multiple species/target organisms, multiple toxicological endpoints, multiple exposure routes; spatial and temporal scales; a product's life cycle; or socio-economic aspects (Suter et al., 2003
What does integrated risk assessment want to achieve?
IRA should not be considered as a new scientific concept but as an evolutionary process which serves the vision of a sustainable and safe use of chemicals in order to protect human health, preserve the environment and maintain the ecosystem services for the benefit of human welfare (Suter et al., 2005), while at the same time better managing the scientific, societal and economic challenges related to present and future safety testing development and chemical policy making.
We believe that IRA
Why is integrated risk assessment needed?
Our vision of IRA addresses the challenges which modern RA practice faces:
- •
For historical and practical reasons, HHRA and ERA for chemicals have generally developed independently and are today typically separated, using largely separate data, models and assumptions to characterize health or environmental risks, which hampers the mutual understanding, exchange and coordination of best RA practices between the human and environmental scientific disciplines (Bridges, 2003, Suter et al., 2005).
- •
This
What is the added value of integrated risk assessment?
IRA answers these scientific, societal and policy needs, because it better manages the balance between increasing public demand for safety and the increasing lack of acceptability of additional animal testing, while reducing at the same time the economic burden of the regulatory system on industry. IRA offers the opportunity for more comprehensive, efficient and cost effective RA (Suter et al., 2005, Vermeire et al., 2007, WHO (World Health Organization), 2001).
A systematically coordinated
What are the opportunities for integrated risk assessment in the present European regulatory landscape?
In recent years, significant scientific advances, changes in the chemical legislation and increasing environmental consciousness have created a favourable scientific and regulatory environment to further develop and promote the concept and vision of IRA. The HEROIC project has identified several opportunities that address general challenges in current RA practice as well as more specific opportunities in selected European regulatory frameworks for chemicals.
What is required for the implementation of integrated risk assessment?
To facilitate the implementation of IRA, the HEROIC project evaluated short-term and medium-term opportunities for the further development, promotion and stepwise implementation of IRA as a feature of European regulatory frameworks in the following areas:
- 1.
Development of RA science (hazard assessment, exposure assessment, mixtures assessment; harmonization of RA terminology, models and methodologies);
- 2.
Regulatory development (including harmonization of legal requirements for HHRA and ERA;
Roadmap
The promotion of the development and implementation of an IRA framework in regulatory practice will require a concerted effort and sustained dialogue between all stakeholders, and will necessitate policy and regulatory changes.
Implementation of a full IRA at larger scale will require international agreement, and major coordination and harmonization efforts.
The following roadmap is proposed:
Acknowledgments
The HEROIC coordination action project was funded under the European Commission's 7th Framework Programme (grant number 282896) with the contribution of the following partners: Thomas Backhaus, Zoran Banjac, Damià Barceló, Jean-Marc Brignon, Ettore Capri, Agathi Charistou, Philippe Ciffroy, Abigail Dalzell, Marinella Farré, Richard Glass, Paola Grasso, Mathias Grotte, Barbara Intelmann, Efrosini Katsanou, Katerina Kyriakopoulou, Kyriaki Machera, Albrecht Paschke, Alexandre Péry, Bertille
References (52)
Human health and environmental risk assessment: the need for a more harmonised and integrated approach
Chemosphere
(2003)- et al.
Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis
Sci. Total Environ.
(2013) - et al.
International programme on chemical safety. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis
Regul. Toxicol. Pharmacol.
(2001) - et al.
An integrated framework for health and ecological risk assessment
Toxicol. Appl. Pharmacol.
(2005) - et al.
Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA)
Regul. Toxicol. Pharmacol.
(2014) - et al.
OSIRIS, a quest for proof of principle for integrated testing strategies of chemicals for four human health endpoints
Regul. Toxicol. Pharmacol.
(2013) The adverse outcome pathway concept: a pragmatic tool in toxicology
Toxicology
(2013)- et al.
Supporting non-experts in judging the credibility of risk assessments (CORA)
Sci. Total Environ.
(2013) - et al.
Integrated testing and intelligent assessment — new challenges under REACH
Environ. Sci. Pollut. Res. Int.
(2008) - et al.
Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment
Environ. Toxicol. Chem.
(2010)
Integrated risk assessment: nonylphenol case study
A framework for integrated environmental health impact assessment of systemic risks
Environ. Health
Integrating emerging technologies into chemical safety assessment
The Expert Panel on the Integrated Testing of Pesticides
Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000 establishing a framework for Community action in the field of water policy
Off. J. Eur. Union
A European Environment and Health Strategy. Communication from the Commission to the Council, the European Parliament and the European Economic and Social Committee. COM (2003) 338 final, Brussels
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC
Off. J. Eur. Union
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products
Off. J. Eur. Union
Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC
Off. J. Eur. Union
Directive 2009/128/EC of the European Parliament and of the Council of 21 October 2009 establishing a framework for Community action to achieve the sustainable use of pesticides
Off. J. Eur. Union
Directive 2009/147/EC of the European Parliament and of the Council of 30 November 2009 on the conservation of wild birds
Off. J. Eur. Union
Common implementation strategy for the Water Framework Directive (2000/60/EC). Guidance Document No. 27: technical guidance for deriving environmental quality standards
SCHER (Scientific Committee on Health and Environmental Risks), SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), SCCS (Scientific Committee on Consumer Safety), making risk assessment more relevant for risk management
Guidance on data sharing. Version 2.0. April 2012 [ECHA-2012-G-01-EN]
Council Directive 92/43/EEC of 21 May 1992 on the conservation of natural habitats and of wild fauna and flora
Off. J. Eur. Union
Science strategy 2012–2016, Warsaw, Poland
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products
Off. J. Eur. Union
Cited by (21)
Techno-economic analysis of phytoremediation: A strategic rethinking
2023, Science of the Total EnvironmentIs the EU chemicals strategy for sustainability a green deal?
2023, Regulatory Toxicology and PharmacologyMulti-actor approaches and engagement strategies to promote the adoption of best groundwater management practices
2022, Current Opinion in Environmental Science and HealthTowards ‘one substance – one assessment’: An analysis of EU chemical registration and aquatic risk assessment frameworks
2021, Journal of Environmental ManagementBehavioral aspects of chemical use: balancing an intrinsic conflict
2017, Current Opinion in Environmental SustainabilityCitation Excerpt :Weighing the risks and benefits of an emerging new technology is more ambiguous and inconsistent for less-familiar technologies (nanotechnology) than for familiar technologies (biofuel) [35]. The importance of social and cultural contexts on balancing behavior (pathway 3) has been evaluated in relation to setting boundaries for chemical pollution [14] and in the execution of integrated risk assessments in which risk-benefit balancing is emphasized [36]. In a survey about the most concerning attributes of construction materials, people from the USA, Germany, and China mentioned the release of hazardous chemicals from the material, while people from India mentioned the strength of the material to support the house structure [37].